Headline
The latest stories from AHA Today.
The Centers for Disease Control and Prevention is investigating hepatitis A outbreaks in multiple states among people reporting drug use and/or homelessness and their contacts.
The U.S. District Court for the Northern District of Mississippi has entered a consent decree prohibiting Delta Pharma from manufacturing or distributing compounded drugs until they comply with the Federal Food, Drug, and Cosmetic Act and FDA regulations.
The Maine health commissioner has appealed a court order requiring the state to submit to the Centers for Medicare & Medicaid Services a state plan amendment ensuring Medicaid eligibility for qualified low-income residents.
The Department of Justice yesterday told a federal court that it would no longer defend key provisions of the Affordable Care Act, including ones that require individuals to have health insurance and protect consumers with pre-existing medical conditions.
The House of Representatives last night voted 210-206 to approve legislation (H.R. 3) that would rescind about $15 billion in prior appropriations to federal programs, including nearly $7 billion from the Children’s Health Insurance Program and $800 million from the Center for Medicare and Medicaid…
The Centers for Medicare & Medicaid Services will host a June 19 webinar on emergency preparedness for providers.
The AHA today released a new resource highlighting the importance of addressing the social determinants of health.
The White House Office of National Drug Control Policy, Truth Initiative and Ad Council yesterday unveiled a public education campaign focused on preventing and reducing misuse of opioids among youth and young adults.
Suicide rates rose in every state but Nevada between 1999 and 2016, climbing 30% or more in 25 states, according to the latest Vital Signs report by the Centers for Disease Control and Prevention.
More than 45 organizations, including the AHA, today encouraged members of the Senate Judiciary Committee to support the Creating and Restoring Equal Access to Equivalent Samples Act.